erlotinib hydrochloride has been researched along with Retinoblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, H; Pei, C; Quyang, L; Shao, Y; Yu, Y; Zhou, Q; Zong, R | 1 |
1 other study(ies) available for erlotinib hydrochloride and Retinoblastoma
| Article | Year |
|---|---|
Erlotinib has tumor inhibitory effect in human retinoblastoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Erlotinib Hydrochloride; Humans; Mice; Neoplasms, Experimental; Retinoblastoma | 2017 |